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LGR5 is known to be a stem cell marker in the murine small intestine and colon, however the localization of
LGR5 in human adenoma samples has not been examined in detail, and previous studies have been limited
by the lack of specific antibodies. Here we used in situ hybridization to specifically examine LGR5 mRNA
expression in a panel of human adenoma and carcinoma samples (n 5 66). We found that a small number of
cells express LGR5 at the base of normal colonic crypts. We then showed that conventional adenomas widely
express high levels of LGR5, and there is no evidence of stereotypic cellular hierarchy. In contrast, serrated
lesions display basal localization of LGR5, and the cellular hierarchy resembles that of a normal crypt.
Moreover, ectopic crypts found in traditional serrated adenomas show basal LGR5 mRNA, indicating that
they replicate the stem cell organization of normal crypts with the development of a cellular hierarchy. These
data imply differences in the stem cell dynamics between the serrated and conventional pathways of
colorectal carcinogenesis. Furthermore we noted high LGR5 expression in invading cells, with later
development of a stem cell niche in adenocarcinomas of all stages.
L
GR5 (Leucine-rich repeat containing G protein-coupled receptor) is a gene encoding for a component of the
Wnt receptor complex, which specifically acts as a receptor for a family of Wnt pathway agonists called R-
spondins. In the mouse antrum, small intestine and stomach the Lgr5-positive stem cells lineage-label - after
marking with a reporter, all differentiated cell lineages normally present in a crypt are seen to be clonally-derived
from Lgr51 cells1,2, and at least in mice, Lgr5 has also been shown to lineage-label gastric and intestinal stem cells.
LGR5 is likely to be a robust stem cell marker in the human intestine also: in situ hybridization shows localization
of LGR5 mRNA to the crypt base mirroring the architecture seen in the mouse3–5. We have shown that the clonal
evolution of human intestinal stem cells is a neutral process, which closely resembles that seen in the murine
crypt, and that human crypts house a similarly small number of functional stem cells6.
In colorectal adenomas our knowledge of stem cell dynamics is also heavily dependent on animal experiments.
Lgr51 cells have been shown to lineage-label within mouse small intestinal adenomas, and a considerable
proportion of the crypt population expresses Lgr5, suggesting a population of hundreds of potential stem cells
in each adenomatous gland7. But recent experiments using continuous clonal labeling in mouse models indicate
that each crypt contains only a small number of functional or ‘working’ stem cells8: and hence it is likely that most
of the Lgr51 population are inconsequential for long-term maintenance of the stem cell pool9. These observations
suggest that few stem cells actually contribute to tumor growth: if this were true for human colorectal adenomas, it
would perhaps account for their observed low growth rate10.
In normal and adenomatous human colonic crypts, we see long-term lineage tracing from the crypt base using
mitochondrial DNA mutations as clonal markers6, suggesting the stem cell population indeed resides in the crypt
base. In human adenomas, there have been claims using aldehyde dehydrogenase 111, crypt base cell markers such
as MSH2, Bcl-2 and survivin12 and the putative cancer stem cell markers CD44, CD166 and EpCAM13 that
progressive overpopulation with stem cells occurs during colon tumorigenesis and drives the development of
colorectal carcinoma. However, none of these markers has been shown even in animal studies to effectively
lineage-label colonic stem cells.
Studies of LGR5 in the human colon have been relatively few; Becker and colleagues used antibodies against
LGR5 to show that in human adenomas LGR5-expressing cells were no longer restricted to the crypt base, but
were found in ‘patches’ at the luminal surface14. A further study reported that the number of LGR5 immunor-
eactive cells with cytoplasmic localization was increased in adenomas, spreading from the gland base to the
surface, again in a patchy distribution pattern15. Immunohistochemistry has also been used to show a negative
relationship between LGR5 expression at the luminal surface of human adenocarcinomas and tumor stage16.
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utilized LGR5 ISH to examine expression of LGR5 in colorectal can-
cers4,5,19. It is of particular note that in regions of colorectal cancers
displaying a glandular organization, expression of putative stem cell
markers (such as LGR5 and EphB2) have been reported to be upre-
gulated at the base of the glandular structures, implying a stem-like
population positioned at the gland base5. However, a detailed ana-
lysis of the LGR5 stem cell architecture in the serrated pathway of
colorectal tumorigenesis, and how it may differ from the classical
adenoma/carcinoma progression has not been reported.
Here we use ISH to systematically study the localization of LGR5
expressing cells in human hyperplastic polyps, adenomas of different
histological sub-types (see Fig. 1) and adenocarcinomas of all stages,
with the aim to detect alterations in their stem cell architecture.
Results
LGR5 is expressed at the crypt base in normal colon and
hyperplastic polyps. To determine if the expression of the stem
cell marker LGR5 is altered during human adenoma progression,
we carried out chromogenic ISH on a panel of human FFPE
hyperplastic polyps, adenomas and adenocarcinomas of all stages
(n 5 66).
We validated the ISH protocol by using a negative control probe
targeting the bacterial gene dapB (Supplementary Fig. S1A).
Furthermore we performed ISH with 3,39-Diaminobenzidine
(DAB)-based detection in addition to Fast Red-based detection,
and verified that both detection methods identify LGR5 expression
within the same cells, thus there was no false positive signal that
could be attributed to the method of detection (Supplementary Fig.
S1B). As previously reported20, we found that in normal human
colonic crypts, Ki67 (MKI67) expression was restricted to the lower
quarter of the crypt, and cytokeratin-20 (KRT20) expression was
only found on the luminal surface, with a portion of the crypt expres-
sing neither proliferation (Ki67) or differentiation (KRT20) markers
(Fig. 2A). Here we used chromogenic ISH to show that normal
human crypts (n 5 7) express LGR5 only in a small number of cells
at the very base of the crypt (Fig. 2A), consistent with reported
isotopic ISH3,10 and expression patterns seen in murine colonic
crypts2. We noted that normal small intestine also expresses LGR5
mRNA in a similarly small number of cells at the crypt base
(Supplementary Fig. S2A and B).
To determine if the organization of the stem cell niche was dis-
rupted in benign lesions, we examined the expression of LGR5 in
hyperplastic polyps (HPPs, n 5 7). HPPs are defined as small, non-
dysplastic serrated lesions of the colon, which are generally thought
to exhibit little or no malignant potential, although certain subtypes
may be precursors to sessile serrated adenomas/polyps21 (see Fig. 1).
All of the HPPs described in this study were small lesions (,5 mm)
and were validated independently by two expert pathologists as hav-
ing no features suggestive of sessile serrated adenomas/polyps (SSA/
Ps). As previously reported20, we found that all HPPs exhibited
KRT20 expression that extends further down into the crypt than in
normal crypts, and there was expansion of the Ki671 population.
Here we report that although LGR5 remained confined to the crypt
base, there was a significant increase in the intensity of LGR5 express-
ion in all hyperplastic crypts examined (Score of normal colon 5 1.27
6 0.12, HPP 5 2.32 6 0.23; p 5 0.002 by the two-sided Student’s t-
test; Fig. 2B, Supplementary Fig. S3). Consistent with this obser-
vation, expression of the putative stem cell marker CD44 also
appeared elevated compared to normal crypts, although remaining
localized to the crypt base (Fig. 2B). We chose to use CD44 as an
additional stem cell marker to validate the LGR5 ISH, as it is one of
the most widely used putative markers of stem cell populations in a
broad range of normal and cancerous tissues22–24.
LGR5 is widely expressed throughout the glands of conventional
adenomas. We next examined conventional adenomas (n 5 17). We
report that within subregions of adenomatous tissue, LGR5 is
Figure 1 | Schematic diagram of the relationship between histological states of the classical and serrated pathways. The upper half of the diagram
represents the serrated pathway of colorectal carcinogenesis. Text in blue describes the genetic features of the serrated pathway (CIMP 5 CpG island
methylator phenotype, MSI 5 microsatellite instability). The text in red describes some of the distinguishing features that are characteristic of the
histological subtypes. The lower half of the diagram represents the classical pathway of carcinogenesis. Text in blue describes the genetic features of the
classical pathway (CIN 5 chromosomal instability).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8654 | DOI: 10.1038/srep08654 2
expressed in cells spread along the entire gland length and at a
relatively uniform level (Fig. 3A, Fig. 4A), an expression pattern
that has been previously documented10. Immunohistochemical
analysis showed that the glands expressing high LGR5 were often
lacking KRT20 expression suggesting the cells were indeed in an
undifferentiated state, and furthermore the expression of the stem
cell marker CD44 was generally moderate throughout such
adenomatous glands (Fig. 3A).
However our data suggests that such a uniformly high expression
pattern is relatively uncommon in conventional adenomas. Within
the majority of lesions we observed little uniformity of LGR5 express-
ion along the gland length and considerable variability in expression
across the adenoma, though still with no apparent conservation of
normal stem cell architecture (Fig. 4B). This ‘patchy’ expression of
LGR5 has previously been reported in colonic adenomas in studies
using LGR5-targeting antibodies14,15. Interestingly, we noted the
presence of structures in which expansion of the LGR5 compartment
was restricted along the length of half of the adenomatous gland
(Fig. 4C), suggestive of dysregulation of the stem cell niche. It is
possible that these glands represent an early stage of the loss of stem
cell architecture, and the stem cell population may be capable of
further expansion until all cells in the gland express LGR5. We fur-
ther noted that within regions of high-grade dysplasia (HGD), there
was a generally higher level of LGR5 expression than within regions
of low-grade dysplasia (LGD; Fig. 4D). Additional examples of the
heterogeneity of LGR5 expression in conventional adenomas can be
found in Supplementary Fig. S4.
LGR5 expression remains basal in serrated adenomas. Although
the majority of colorectal cancers arise via the conventional
adenoma-carcinoma pathway, approximately 10–20% of colorectal
carcinomas are thought to arise from serrated lesions25. These
tumors follow a different pathway of progression from adenoma to
carcinoma (Fig. 1), and have a distinct genetic and epigenetic profile
to their non-serrated counterparts26, and it has been proposed that
serrated lesions can be identified by differential expression of certain
markers27. We therefore sought to determine if the disruption of the
stem cell niche was a feature of the crypts of sessile serrated
adenomas/polyps (SSA/Ps) and traditional serrated adenomas
(TSAs).
We found that SSA/Ps (n 5 7) displayed expansion of the LGR5-
expressing compartment, although unlike conventional adenomas
we saw that LGR5 in SSA/Ps remained generally localized to cells
in the base of the crypt (Fig. 3B). The expression of LGR5 was
increased in SSA/Ps compared to normal crypts and HPPs (Score
of SSA/Ps 5 3.25 6 0.13, HPP 5 2.32 6 0.23; p 5 0.003 by the two-
sided Student’s t-test, Supplementary Fig. S3), consistent with a
report suggesting that the putative stem cell marker CD133 is more
highly expressed in SSA/Ps than HPPs28. The expression of CD44
was more extensive than normal or hyperplastic crypts, although still
localized to the crypt base (Fig. 3B). SSA/Ps frequently displayed
expansion of the Ki671 population compared to normal crypts,
and KRT20 expression was generally no longer confined to the upper
third as it was in HPPs (Fig. 3B).
We also examined traditional serrated adenomas (TSAs, n 5 6),
and report that these also appeared to maintain a near-normal stem
cell architecture. As with SSA/Ps, LGR5 expression was significantly
increased relative to normal crypts (Score of TSAs 5 2.73 6 0.28,
normal colon 5 1.27 6 0.12, p , 0.0001 by the two-sided Student’s t-
test, Supplementary Fig. S3) yet restricted to the base of the crypts,
and the expression patterns of Ki67, KRT20 and CD44 resembled
that of the normal crypt (Fig. 2C).
LGR5 is expressed at the base of ectopic crypts in TSAs. Ectopic
crypts are a defining feature of TSAs in which small crypts grow
laterally from the side of the original crypt20. We identified regions
Figure 2 | Stem cell architecture in human normal colon and hyperplastic polyps. Representative H&E staining, in situ hybridization (LGR5; pink)
and immunohistochemical staining (Ki67, KRT20, CD44; brown) in human colon samples, illustrating the normal stem cell architecture (A,
site 5 ascending colon) and the maintenance of a stem cell niche in hyperplastic polyps (HPPs, B, site 5 descending colon). Black arrows indicate LGR5
positivity at the base of crypts. Scale bars represent 200 micron, scale bars of inserts represent 50 micron.
www.nature.com/scientificreports
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containing ectopic crypts in the TSAs that were analyzed for LGR5
expression, and present novel evidence to show that these crypts
contain a small population of LGR5-expressing cells at the base.
This suggests that the growth of ectopic crypts is supported by
LGR5-positive cells within a ‘mini stem cell niche’ (Fig. 5). The
ectopic crypts also displayed localization of Ki67, KRT20 and
CD44 expression (Fig. 5) that closely resembled that of a normal
crypt, suggesting that a cellular hierarchy is established within
ectopic crypts.
Carcinomas of all stages display basal localization of LGR5. It has
been reported that human colorectal cancers can contain an LGR5-
expressing stem cell niche at the base of tumor glands resembling
crypts4,5. We therefore analyzed LGR5 ISH and Ki67, KRT20 and
CD44 IHC in 23 adenocarcinomas of all stages (pT1: n 5 9, pT2: n 5
3, pT3: n 5 7, pT4: n 5 4). Of these 23 adenocarcinoma samples, 18
were found to be suitable for LGR5 ISH analysis, and consistent with
the previous reports we generally observed LGR5 expression in the
proximal portion of the gland in adenocarcinomas of all clinical
stages (Fig. 6A, B and Supplementary Fig. S5). The localization of
Ki67 and KRT20 was also compartmentalized basally and therefore
reminiscent of the normal stem cell architecture (Fig. 6A, B),
suggesting a cellular hierarchy is indeed present. We did not note a
difference in LGR5 expression between stages, however we recognize
that this analysis may be confounded by our small sample number, as
well as by poor or inconsistent fixation of resection specimens,
therefore we did not perform detailed quantitative analysis of
LGR5 expression in cancers.
We analyzed the level of Ki67, KRT20 and CD44 expression in the
adenocarcinomas (n 5 23) by using a four grade semi-quantitative
scoring system with 0 representing no staining and 3 representing the
strongest staining (Supplementary Fig. S6, A). We report that carci-
nomas of all clinical stages almost exclusively express moderate or
high levels of Ki67 (Supplementary Fig. S6, B), even in invasive cells.
This is in apparent contrast to a previous report29 in which low Ki67
was described at the invasive front, however such comparisons are
confounded by inconsistency of staining protocols and inter-obser-
ver heterogeneity. The expression of KRT20 and CD44 displayed
much more inter-sample heterogeneity with tumors displaying a
large range of antigen expression (Supplementary Fig. S6, B), how-
ever our sample size was too small to permit a statistical comparison
between clinical stages or sites of disease.
The expression of LGR5 has been reported to be correlated with
invasion and metastasis of gastric cancer30. We therefore sought to
Figure 3 | Stem cell architecture in human adenomas. Representative H&E staining, in situ hybridization (LGR5; pink) and immunohistochemical
staining (Ki67, KRT20, CD44; brown) in human colon samples, illustrating the absence of stem cell architecture in a conventional adenoma (A, site 5
transverse colon), and the maintenance of a relatively normal stem cell niche in a sessile serrated adenoma/polyp (SSA/P, B, site 5 caecum) and a
traditional serrated adenoma (TSA, C, site 5 rectum). Black arrows indicate LGR5 positivity at the base of crypts. Scale bars represent 200 micron, scale
bars of inserts represent 50 micron.
www.nature.com/scientificreports
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Figure 4 | Diversity of LGR5 expression in conventional adenomas. (A). Representative image of homogenous LGR5 expression throughout the
adenomatous glands (site 5 transverse colon). (B). Representative image of heterogeneous LGR5 expression in a lesion (site 5 rectosigmoid).
(C). Representative image of an adenomatous gland in which one branch expresses high LGR5, with the other half expressing low LGR5, suggestive of early
dysregulation of the stem cell niche (site 5 rectosigmoid). (D). Representative images of LGR5 expression within an adenoma (site 5 rectosigmoid) that contains
regions of high-grade dysplasia (HGD) and low-grade dysplasia (LGD). Scale bars in A-D represent 200 micron, scale bars in inserts represent 50 micron.
Figure 5 | Expression of LGR5 in ectopic crypts. Representative images showing expression of LGR5 and Ki67 in ectopic crypts of a traditional serrated
adenoma (TSA, site 5 sigmoid colon). Black arrows identify LGR5 positivity at the base of ectopic crypts. Scale bars represent 100 micron, scale bars of
inserts represent 20 micron.
www.nature.com/scientificreports
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examine LGR5 expression within invasive cell populations in our
samples, and noted that LGR5 expression was generally high in
populations of invading cells (Fig. 6C), implying a massive expansion
in stem cell number during this process. We noted that these small
clusters of invasive cells generally express high CD44 and low KRT20
(Fig. 6C), indicating they are indeed in a non-differentiated state. In
comparing the invasive front of early and late stage adenocarcino-
mas, we noted no clear difference between sample groups. However,
we recognize that such analyses can be hampered by the confounding
orientation of samples within FFPE blocks, and also by poor or
inconsistent fixation of resection specimens.
Discussion
LGR5 is accepted as the most reliable intestinal stem cell marker
currently in use, however the expression and localization of the
receptor in human adenomatous crypts or glands remains the subject
of much debate. A previously published report has suggested that the
organization of the cell hierarchy within murine adenomas closely
resembles that of the normal crypt, with Lgr5 expression remaining
at the crypt base7. However there is also evidence to suggest that in
the human colon, stem cell architecture is lost during the develop-
ment of adenomas, and that expression of the colonic stem cell
marker LGR5 is widespread throughout adenomatous glands10.
This report clarifies these discrepancies by providing new evidence
that while conventional adenomas have a disrupted stem cell archi-
tecture as determined by frequent and widespread non-basal
expression of LGR5, the stem cell architecture is remarkably con-
served in HPPs, SSA/Ps and TSAs.
We detected significantly elevated levels of LGR5 mRNA in all
serrated lesions examined (HPPs, SSA/Ps and TSAs; n 5 20), and
this was generally accompanied by expansion of the proliferative
(Ki671) and differentiated (KRT201) compartments. However
LGR5 expression remained universally basal and the stem cell archi-
tecture resembled that of a normal crypt, suggesting a stem cell niche
was present and functional.
It is of particular interest that LGR5 was expressed basally in the
ectopic crypts of TSAs, with an associated cellular hierarchy. These
structures extend laterally from crypts of a TSA, and little is known
about the mechanism of their formation, although in the murine
colon it has been proposed to be due to a repression of bone mor-
phogenetic protein (BMP) signaling31. The observation that ectopic
crypts express basal LGR5 suggests that their growth is indeed sus-
tained by cell division within a ‘mini stem cell niche’. Whether LGR5-
positive stem cells migrate from the base of the adenomatous crypt to
Figure 6 | Expression of LGR5 in invasion and adenocarcinoma. (A). Representative images showing basal LGR5 expression in adenocarcinoma
structures resembling crypts in an early stage cancer (pT1, site 5 sigmoid colon). (B). Representative images showing basal LGR5 expression in
adenocarcinoma structures resembling crypts in a late stage cancer (pT3, site 5 sigmoid colon). (C). Representative images showing universally high
LGR5 expression in an invasive cell population found within a conventional adenoma (site 5 sigmoid colon). Scale bars in A, B and C represent 500
micron, scale bars of inserts represent 100 micron.
www.nature.com/scientificreports
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these ‘mini niches’, or a niche forms de novo due to changes in
stromal signals (such as BMP) remains unclear.
This apparent conservation of the stem cell niche in serrated
lesions is in striking contrast to the expression patterns in conven-
tional adenomas. In all non-serrated lesions analyzed (n 5 17), we
saw that LGR5 was no longer confined to the base of the glands and
was generally widely expressed throughout the lesion, although con-
siderable heterogeneity in the level of expression was often observed.
We provided evidence of adenomatous glands that expressed LGR5
only on one side or branch, a feature that implied during conven-
tional adenoma progression LGR5-positive cells are no longer con-
fined to the crypt base. This data is consistent with previous reports
suggesting that mouse7 and human10 adenomatous glands display a
dramatic increase in the number of LGR5-positive cells.
We note that in the murine colon, only a small percentage of the
total Lgr5-expressing cells actually function as stem cells at any one
time8, though they are all endowed with stem cell potential9. In
addition, we have recently shown that normal human colonic crypts
are sustained by a small number of ‘functional’ stem cells (similar to
that of murine crypts), however adenomatous crypts display an ele-
vated number of functional stem cells6. Thus, applying this insight to
conventional adenomas, the large number of LGR51 cells suggests a
large pool of cells with stem cell potential, but not necessarily a large
number of functioning stem cells.
LGR5 is reported to positively regulate invasion and metastasis
of gastric cancer via a matrix metalloproteinase 2 (MMP2)-
dependent mechanism30, however in vitro and mouse xenograft
models of colorectal cancer have shown that LGR5 knockdown
increases invasion32. Our analysis revealed that LGR5-positive cells
are substantially enriched in invasive cell populations, suggesting
that LGR5 can support invasion rather than inhibit it. These
results imply that the plasticity of the stem-like state may be
permissive for invasion, allowing the cells to disseminate from
the glands of the adenoma and invade through the muscularis
mucosae. This expansion in stem cell number that occurs upon
invasion is also seen in lineage-labelled murine stem cells,
whereby measurements of clone size and proliferative potential
in invasive squamous cell carcinoma showed geometric expansion
of the stem cell population33.
Interestingly, a previous report suggests that in established human
colon carcinomas, LGR5 expression remains basal and is exclusive
from KRT20 expression5. We were able to examine LGR5 expression
in 18 cases of adenocarcinoma, and consistent with the findings of
Merlos-Suarez and colleagues, we report that in the majority of
established carcinomas with a glandular structure, compartmentali-
zation of LGR5 and KRT20 is present. Combined with the obser-
vation of universally high LGR5 in invasive cells, this lends itself to
the hypothesis that the LGR5-positive population is responsible for
the early stages of invasion.
In summary, this study applied ISH to a panel of human FFPE
normal colon, adenoma and carcinoma samples (n 5 66) to show
that conventional adenomas display extensive expression of the
stem cell marker LGR5, and this expression is no longer restricted
to the base of adenomatous crypts. However, in serrated lesions,
although LGR5 expression is upregulated, the basal localization is
retained and the cellular organization within the crypt resembles
the normal colon. These are significant observations, as there is
little currently known about the histogenesis of serrated adeno-
mas, although the origin of conventional adenomas has been
intensively investigated34,35. Our findings may reflect an important
difference in their origin and mode of progression. Moreover, we
note that significant shortcomings in the routine diagnosis of
serrated colorectal polyps have been reported36, and due to its
consistent basal localization in serrated lesions, the examination
of LGR5 distribution might play a role in improving discrimina-
tion of these enigmatic lesions.
Methods
All methods were carried out in accordance with approved institutional guidelines,
and experimental protocols were approved by the Research Ethics Committee (07/
Q1604/17 and 11/LO/1613). Samples were collected in accordance with UK Home
Office regulations, with all patients giving informed consent.
Patient samples. Formalin-fixed paraffin embedded (FFPE) human tissue samples (n
5 66) were obtained from University College Hospital, London. Histopathological
classification of each patient sample was independently carried out by two expert
pathologists (NAW and MRJ).
In situ hybridization (ISH). ISH for LGR5 expression was performed on 5 mm
sections using the RNAscope 2.0 High Definition (Red, catalog number 310036, or
Brown, catalog number 310035) assay according to the manufacturers instructions
(Advanced Cell Diagnostics, Hayward, CA). Briefly, samples were baked at 60uC for
1 hour, followed by deparaffinization and incubation with Pretreat 1 buffer for 10
minutes at room temperature (RT). Slides were boiled in Pretreat 2 buffer for 15
minutes, followed by incubation with Pretreat 3 buffer for 30 minutes at 40uC. Slides
were incubated with the relevant probes for 2 hours at 40uC, followed by successive
incubations with Amp1 to 6 reagents. Staining was visualized with 3,39-
diaminobenzine (DAB) or Fast Red for 10 minutes, then lightly counterstained with
Gill’s haemotoxylin. RNAscope probes used were LGR5 (NM_003667.2, region 560–
1589, catalog number 311021), POLR2A (positive control probe, NM_000937.4,
region 2514–3433, catalog number 310451) and dapB (negative control probe,
EF191515, region 414–862, catalog number 310043). LGR5 expression at the crypt
base was quantified according to the five-grade scoring system recommended by the
manufacturer (0 5 No staining or less than 1 dot to every 10 cells (403
magnification), 1 5 1–3 dots/cell (visible at 20–403 magnification), 2 5 4–10 dots/
cell, very few dot clusters (visible at 20–403 magnification), 3 5 . 10 dots/cell, less
than 10% positive cells have dot clusters (visible at 203 magnification), 4 5 . 10
dots/cell. More than 10% positive cells have dot clusters (visible at 203
magnification)). At least 3 patients per sample group, with an average of 25 crypts
scored per sample group were scored, a number that was limited by the number of
well-orientated crypts that were present in each tissue section.
Immunohistochemistry (IHC). IHC was performed according to standard protocol.
Briefly, 5 mm serial sections were dewaxed, rehydrated and immersed in 3% hydrogen
peroxide for 20 minutes to quench endogenous peroxidase activity. Antigen retrieval
was carried out at 95uC for 20 minutes in sodium citrate buffer (pH 6.0). After cooling,
sections were incubated with blocking buffer (PBS supplemented with 2% goat serum
and 1% bovine serum albumin) for 1 hour at RT. Primary antibodies were applied for
1 hour at RT (rabbit anti-human Ki67 [ab92742] at 152000 dilution, Abcam plc,
Cambridge, UK; mouse anti-human CD44 [NCL-CD44-2] at 15100, Novocastra
Laboratories Ltd, Newcastle upon Tyne, UK; mouse anti-human cytokeratin-20
[M7019] at 1575, Dako, Cambridgeshire, UK). Sections were then incubated with a
biotinylated secondary antibody at RT for 45 min, followed by incubation with
peroxidase-conjugated streptavidin solution at RT for 45 min. Visualization of
antibody binding was carried out using DAB and sections were lightly counterstained
using Gill’s haematoxylin. Intensity of antigen expression in adenocarcinomas was
semi-quantitatively scored using a four grade system, with 0 representing no
expression, 1 representing weak expression, 2 representing moderate expression and
3 representing strong expression.
Statistical analysis. Data are presented as mean 6 standard error of the mean (SEM).
Analysis was performed using the two-sided Student’s t test, and considered
statistically significant when the p value was less than 0.05.
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